Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Tobacco Abuse & Nicotine Addiction (Adv Science to Reduce Tobacco Abuse & Nic...

University of Toronto

$78,360.00

Current State and Perspectives on Health Insurance Coverage of Smoking Cessation Treatment in Ontario

FY 2009-10

Summary
Tobacco use kills about 13, 000 Ontarians very year and results in almost $6.0 billion in direct health care expenditures and lost productivity. A key strategy to reduce the tobacco related morbidity and mortality is to increase the use of effective smoking cessation interventions. Pharmacological and psychosocial cessation interventions incur costs not generally covered by the Ontario provincial health insurance plan. Scientific evidence indicates that the provision of insurance coverage for smoking cessation treatments encourages the use of treatments and increases cessation. Public health experts have recommended that all insurance plans cover evidence-based smoking cessation treatments as a lifetime benefit. Preliminary evidences indicates that Ontario based health benefit plans provide coverage for only limited types of pharmacotherapy (e.g. bupropion), while excluding other medications, such as nicotine replacement therapy, and psychosocial interventions. Yet in other jurisdictions health benefit plans cover a wide range of effective cessation services. The proposed study aims to assess current government incentives and regulatory policies that affect insurer decisions regarding coverage of cessation interventions in health benefit packages. We will: study the current state of health insurance coverage of cessation benefits in Ontario; explore how insurers make decisions on the extent of coverage; identify the major barriers faced by health insurers and employers in expanding the coverage for smoking cessation services; examine the effects of incentives and regulatory policies in other jurisdictions on coverage, uptake, reach and cessation rates; and provide strategic policy recommendations.
Program
Tobacco Abuse & Nicotine Addiction (Adv Science to Reduce Tobacco Abuse & Nic...
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
191913
Name
Schwartz Robert M
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Health systems / services
Prcname2
Catalyst Grant: Prevention and Treatment of Illicit Substance Use
Projecttitle
Current State and Perspectives on Health Insurance Coverage of Smoking Cessation Treatment in Ontario
Programtype2
Operating Grants
Orgnameinp2
University of Toronto
Cihramount2
$78,360
Cihrequipment2
$0
Programname2
Tobacco Abuse & Nicotine Addiction (Adv Science to Reduce Tobacco Abuse & Nic...
Keyworddelim
Comprehensive Case Studies; Evidence-Based Smoking Cessation Treatments; Exploratory Qualitative Approach; Health Insurance; Key-Informant Interviews; Literature Review
Abstract
Tobacco use kills about 13, 000 Ontarians very year and results in almost $6.0 billion in direct health care expenditures and lost productivity. A key strategy to reduce the tobacco related morbidity and mortality is to increase the use of effective smoking cessation interventions. Pharmacological and psychosocial cessation interventions incur costs not generally covered by the Ontario provincial health insurance plan. Scientific evidence indicates that the provision of insurance coverage for smoking cessation treatments encourages the use of treatments and increases cessation. Public health experts have recommended that all insurance plans cover evidence-based smoking cessation treatments as a lifetime benefit. Preliminary evidences indicates that Ontario based health benefit plans provide coverage for only limited types of pharmacotherapy (e.g. bupropion), while excluding other medications, such as nicotine replacement therapy, and psychosocial interventions. Yet in other jurisdictions health benefit plans cover a wide range of effective cessation services. The proposed study aims to assess current government incentives and regulatory policies that affect insurer decisions regarding coverage of cessation interventions in health benefit packages. We will: study the current state of health insurance coverage of cessation benefits in Ontario; explore how insurers make decisions on the extent of coverage; identify the major barriers faced by health insurers and employers in expanding the coverage for smoking cessation services; examine the effects of incentives and regulatory policies in other jurisdictions on coverage, uptake, reach and cessation rates; and provide strategic policy recommendations.
Competitiondate
200911
Approvedterm2
1 yr 0 mth
Pinamesdelim
Schwartz, Robert M; Ferrence, Roberta G
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $78,360~ $0~